Skip to main content

Table 1 Clinicopathological parameters

From: Response to neoadjuvant chemotherapy based on pathologic complete response in very young patients with ER-positive breast cancer: a large, multicenter, observational study

Variables

ER-Positive

ER-Negative

Age<35

35≤Age≤50

P-value

Age<35

35≤Age≤50

P-value

(N = 147)

(N = 901)

(N = 134)

(N = 663)

Year of diagnosis

     

0.585

 1991–1995

1 (0.7)

3 (0.3)

 

1 (0.7)

2 (0.3)

 

 1996–2000

4 (2.7)

3 (0.3)

 

1 (0.7)

8 (1.2)

 

 2001–2005

24 (16.3)

111 (12.3)

 

25 (18.7)

97 (14.6)

 

 2006–2010

90 (61.2)

557 (61.8)

 

75 (56.0)

411 (62.5)

 

 2011–2013

28 (19.0)

227 (25.2)

 

32 (23.9)

145 (23.9)

 

Histology

  

0.696

  

0.924

 Ductal

140 (95.2)

846 (93.9)

 

128 (95.5)

633 (95.5)

 

 Lobular

3 (2.0)

30 (3.3)

 

0 (0.0)

2 (0.3)

 

 Other

1 (0.7)

5 (0.6)

 

2 (1.5)

8 (1.2)

 

 Unknown

3 (2.0)

20 (2.2)

 

4 (3.0)

20 (3.0)

 

PR

  

0.379

  

0.674

 Negative

45 (30.6)

244 (27.1)

 

115 (85.8)

578 (87.2)

 

 Positive

102 (69.4)

656 (72.8)

 

19 (14.2)

85 (12.8)

 

 Unknown

0 (0.0)

1 (0.1)

 

0 (0.0)

0 (0.0)

 

HER2

  

0.404

  

0.012

 Negative

106 (73.6)

674 (75.6)

 

104 (77.6)

429 (64.9)

 

 Positive

37 (25.7)

215 (24.1)

 

29 (21.6)

218 (33.0)

 

 Unknown

4 (2.7)

12 (1.3)

 

1 (0.7)

16 (2.4)

 

Clinical Tumor size

  

1.000

  

0.745

 ≤ 2 cm

3 (2.0)

20 (2.2)

 

2 (1.5)

14 (2.1)

 

 > 2 cm

49 (33.3)

290 (32.2)

 

51 (38.1)

210 (31.7)

 

 Unknown

95 (64.6)

591 (65.6)

 

81 (60.4)

439 (66.2)

 

Palpability

  

0.175

  

0.160

 Nonpalpable

1 (0.7)

29 (3.2)

 

1 (0.7)

27 (4.1)

 

 Palpable

113 (76.9

650 (72.1)

 

95 (70.9)

459 (69.2)

 

 Unknown

33 (22.4)

222 (24.6)

 

38 (28.4)

177 (26.7)

 

Nucleus grade

  

0.110

  

0.102

 I

10 (6.8)

85 (9.4)

 

1 (0.7)

14 (2.1)

 

 II

48 (32.7)

359 (39.8)

 

28 (20.9)

106 (16.0)

 

 III

54 (36.7)

271 (30.1)

 

57 (42.6)

350 (52.8)

 

 Unknown

35 (23.8)

186 (20.6)

 

48 (35.8)

193 (29.1)

 

Proliferative index

  

0.001

  

0.006

 Low

79 (53.7)

612 (67.9)

 

19 (14.2)

184 (27.8)

 

 High

52 (35.4)

210 (23.3)

 

91 (67.9)

378 (57.0)

 

 Unknown

16 (10.9)

79 (8.8)

 

24 (17.9)

74 (11.2)

 
  1. NOTE: Data are presented as No. (%) unless otherwise specified
  2. ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor 2